Vaccination is an important tool in poultry health, but is itself a stressor often resulting in a reduction in feed intake, body weight gain, and nutrient digestibility. In other species, vaccination is associated with an immediate acute-phase response. As an important immune parameter, the circulating heterophil/lymphocyte (H/L) ratio is a well-recognized parameter of stress in poultry. In this study, the effects of a routinely used commercial poultry vaccine on the acute phase response (APR) and H/L ratios in specific pathogen-free (SPF) layer chicks was examined to determine if post vaccination (PV) stress and an APR occur. A combined Newcastle disease and infectious bronchitis vaccine (Nobalis Ma5+Clone 30) was administered to SPF chicks by the intraocular route at age 7 d. Acute phase proteins (APP), alpha-1 acid glycoprotein (AGP) and serum amyloid A (SAA) were measured by enzyme-linked immunosorbent assays at d 0 (pre-vaccination) and d 0.5, 1, 2, 3, 4, 5, 6, and 21 PV. Stress was determined in the chicks by measurement of the H/L ratio. The immune response to the vaccine was estimated by measurement of the antibody (IgY) response to the vaccine at d 21.
INTRODUCTION
Acute phase proteins (APP) are a group of blood proteins involved in restoring homeostatic balance by restricting growth of microorganisms, mediating the inflammatory response and the effects of stress through an antibody-independent response. The APP are also considered to have diagnostic and prognostic potential because of the correlation between their concentration in blood and the response of the host to infection or inflammation (Cray et al., 2009) . There is increasing interest in APPs in chickens as a physiological marker for health and welfare, including infection and intriguing vaccine response to both bacterial and viral pathogens (O'Reilly and Eckersall, 2014) . Re-C 2017 Poultry Science Association Inc. Received July 6, 2017. Accepted October 26, 2017. 1 Corresponding author: David.Eckersall@glasgow.ac.uk sponses of APP in terms of vaccination stimuli have been investigated in other species; for instance, in horses (Andersen et al., 2012) , sheep (Eckersall et al., 2008) and calves (Arthington et al., 2013) . These previous studies reported an acute phase response to a variety of vaccines and therefore suggest the possibility that monitoring the APP may be a means to determine the efficacy of a vaccine in stimulating the innate immune system and as such could be a tool of value in vaccine development.
In chickens, alpha-1 acid glycoprotein (AGP) responds as a moderate positive APP (Chamanza et al., 1999; O'Reilly and Eckersall, 2014) following experimental infection. Investigation of the plasma AGP response, in White Leghorn SPF chickens at age 3 wk old, inoculated by an intraocular route with a highly virulent strain of Gumboro disease virus, showed a 4.6-fold increase in serum AGP concentration at 2 d post immunization, which peaked at 6 d at 6.2-fold the pre-treatment level. In contrast, inoculation with an 463 attenuated strain of Gumboro disease virus lead to a peak in AGP of 2.4-fold at d 2 post inoculation (Inoue et al., 1997) . AGP levels have also been shown to increase significantly (P < 0.05), at 12 to 48 h post IV injection with lipopolysaccharide (LPS) from Escherichia coli in male broiler chickens at 3 wk old (Takahashi et al., 1998) Inoculation of commercial layer chickens with Mycoplasma gallisepticum vaccine caused a significant increase in serum AGP concentration, which started at 1 d PV (Peebles et al., 2014) . In this study, the vaccine was administered via the intraocular route in one group and subcutaneous injection in another group. The concentration of AGP remained significantly higher, in both administration routes, than in the control group for up to 21 d post inoculation.
Serum amyloid A (SAA) is another major positive APP in chickens (Alasonyalilar et al., 2006) and is immunomodulatory, inhibiting pyrexia and down regulating pro-inflammatory events during an APR (Shainkinkestenbaum et al., 1991; Uhlar and Whitehead, 1999 ). However, due to the lack of commercial assay systems, there have been few reports on this APP in chickens and none in relation to post vaccination (PV) stimulation. In this study we were able to monitor SAA in chicken serum using a newly available species-specific enzyme-linked immunosorbent assay (ELISA) system and therefore determine if this major APP is also stimulated by vaccination.
Changes in white blood cell count, especially in heterophils/lymphocyte (H/L) ratio, have been used as a measure of stress in chickens (Gross and Siegel, 1983; Shini et al., 2008) (Crowther, 2009; Ohara et al., 2015) . The H/L ratio of birds can be affected by health disturbance or stress (Crowther, 2009) , including transport stress (Huff et al., 2005; Matur et al., 2016) , possibly due to the transition of leukocytes from the marginal pool to peripheral circulation (Duncan, 1987) .
In this study, we measured the AGP, SAA, and the H/L ratio in specific pathogen-free (SPF) chickens following routine vaccination via the intra-ocular route to determine whether the immediate post-vaccination innate immune or stress response was most sensitive to the mild or severe vaccination stress. Our specific aim was to determine if an immediate APP response occurs following intra-ocular vaccination as well as via the intra muscular route (Peebles et al., 2014) which would allow subsequent investigations on the pathophysiology of avian APPs and their interaction with the protection of the host provided by such vaccination. The vaccine chosen for the study, a combined Newcastle disease and infectious bronchitis (N/B) live, freeze-dried virus vaccine, is routinely used in chicken production, and this dual vaccine was selected to stimulate an APP response under conditions similar to those on commercial farms. Vaccination routes recommended for this vaccine are by spray, in drinking water or by eye drop. Intraocular vaccination (eye drop) was selected to ensure every individual bird received the same dose, which could not be guaranteed with the other routes. To evaluate the success of the vaccine, the amount of specific antibody (IgY) raised against the immunogen proteins of the vaccine after 21 d, was also determined.
MATERIAL AND METHODS

SPF Chicks and Housing
One hundred and eighty 1-day-old SPF White leghorn layer chicks were hatched out at the experimental farm (Cochno Research Farm, University of Glasgow) and divided into 2 batches each containing 90 chicks. Each batch of chicks was then placed in a separate, controlled-environment room (R1 and R2) in one of 2 pens (n = 45 per pen). The 2 pens in each room had a litter of wood shavings and were fitted with a brooding ring. The stocking density was 12 chicks/m 2 . The chicks were fed ad libitum with a commercially available chick crumb formulated to meet or exceed National Research Council (NRC, 1994) guidelines, and the birds had access to fresh water throughout the study period. The light, temperature, and ventilation within each room were automatically controlled and adjusted according to management guide recommendations. The chicks were allowed to adjust to their environment for the first 7 d before the experiment commenced. Strict biosecurity was applied to prevent cross contamination between the 2 rooms and each pen, not least the controls (R2) were always visited first and then the vaccinated room (R1).
Experimental Design
The experiment commenced when the chicks were 7 d old. There were 9 sampling time points; pre (d 0) and PV at 12 h, 24 h, and then 2, 3, 4, 5, 6, and 21 d thereafter. At each time point, 12 chicks were weighed and culled and samples collected, 6 per treatment and 3 per replicate pen. Full ethics approval was granted in advance by the University of Glasgow MVLS College Ethics Committee.
Vaccine and Vaccination
A commercially available combined Newcastle disease and infectious bronchitis (N/B) live, freeze-dried virus vaccine (Nobalis Ma5+Clone 30, MSD Animal Health) was used in this experiment. After re-constituting the vaccine in sterile saline solution, each dose contained at least 10 3.5 EID 50 of the IB strain Ma5 and 10 6 EID 50 Newcastle disease virus strain Clone 30.
The chicks in pens 1 and 2 in R1 were weighed and the vaccine was administered by the intra-ocular route with one drop applied to one eye. A sterile saline solution was administered by the same route to control animals in pens 1 and 2, which were housed in R2.
Blood Sampling and Assessment
At each sampling time point, 3 chicks were chosen from each replicate pen, weighed, then humanely culled by dislocation of the neck followed by decapitation. Following decapitation, approximately 1.5 mL of blood was collected from the major vessels in the neck using heparinized tubes. Fresh blood was used to make blood smears to determine the H/L ratio; the remainder was centrifuged (3,000 × g) for 15 min at 4
• C and the plasma immediately frozen at −20
• C. SAA and AGP levels were measured in all samples collected using commercially available ELISA kits described below. Plasma from samples on d 0 and 21 d were used to estimate the antibody titers as detailed below.
Heterophil/Lymphocyte Ratios
Differential white blood cell (WBC) counts were carried out on the blood smears stained with the MayGrunwald-Giemsa stain. Two hundred leukocytes were counted and classified per slide. The H/L ratio was calculated by dividing the total number of heterophils by the total number of lymphocytes (Gross and Siegel, 1983; Ohara et al., 2015) . Samples used for this technique were at 0, 1, 2, 3, 4, 5, 6 d PV, and we dropped 12 h PV for technical issues.
Antibody Titer Raised Against the Vaccine
A modified antibody (Ab) titration assay (Snyder et al., 1983; Crowther, 2009 ) was used to determine the amount of IgY Ab raised against the vaccine in this study. A 96-well plate (Costar Assay Plate, Corning) was coated with the Newcastle and infectious bronchitis vaccine (Nobalis Ma5+Clone 30) diluted to a protein concentration of 20 μg/mL in 0.2 M carbonate bicarbonate buffer at pH 9.5 and incubated at 4
• C overnight. The protein content of the vaccine had been determined by a Bradford protein assay (Sigma Chem Co. Poole, UK) with bovine serum albumin as the standard. Each well was then aspirated and washed 4 times using Tris-buffer saline (TBS) 50 mM Tris-Cl, pH 7.5 containing 0.05% tween-20. Wells were blocked with 200 μL of 5% (w/v) Marvel milk protein diluted in TBS-T (0.05%) over 1 h at room temperature (RT) on a rocking plate. The plate was then washed as above.
Antibody standards were made by serially diluting pooled samples collected from vaccinated birds sampled at 21 d PV and by diluting 1:20 in TBS-T with 0.5% Marvel milk. This was standard 1 (S1) and given a value of 100 arbitrary units (AU) of antibody. It was then diluted in a 6-fold serial dilution to S6 (3.13 AU) using TBS-T with 0.5% Marvel milk. The chicken serum samples also were diluted 1:80 in TBS-T 0.5% Marvel milk. To duplicate wells a 100 μL aliquot of diluted standard or sample was added. After 1 h, incubation with constant shaking at RT, the plate was washed as above. The second antibody, anti-Chicken IgY VHH Single Domain Antibody conjugated to horseradish peroxidase (HRP) (Abcam, Cambridge, UK), was diluted to a concentration of 1:5000 with TBS-T 0.5% Marvel milk and added before incubating for another 1 h at RT by constant shaking, then washed as above. 100 μL of tetra-methylbenzidine (TMB, KPL Laboratories, Inc., Gaithersburg, MD) was then added to each well for 20 min at RT while rocking until a blue color developed, then 100 μL of stop solution (2 M H 2 SO 4 ) was added. This caused the color to change to yellow. The absorbance of the resulting solution was measured at 450 nm using an OPTIMA absorbance microplate reader (BMG Labtech Ltd, Bucks, UK). A standard curve using 4-parameter fit curve was used to determine the antibody response.
Enzyme-Linked Immunosorbent Assays (ELISA)
The ELISA assays for chicken APPs were obtained from Life Diagnostics Inc., (West Chester, PA). They were performed according to the manufacturer's instructions with a dilution factor for the serum samples of 1:10,000 for AGP and 1:20 for SAA. Each individual sample was run in duplicate.
ELISA Assay for AGP
Diluted samples and standards were mixed thoroughly and 100 μL of each sample or standard was dispensed into duplicate wells of a 96-well microtiter plate. This was then incubated on an orbital microplate shaker at 150 revolutions per min (rpm) at RT for 45 min. Contents of the wells were then discarded and the wells were washed 5 times each using 1× wash buffer. After ensuring all residual droplets in the wells were removed by striking plates onto absorbent paper, 100 μL of the secondary antibody-HRP conjugate was then dispensed into each well and incubated on the shaker at RT for 45 min. The wash step was repeated and 100 μL of TMB reagent (HRP substrate) was dispensed into wells and a blue color development was allowed to proceed for 20 min on the shaker at RT. The reaction was stopped by adding 100 μL of stop solution per well into the wells. Absorbance was read using a FLUOstar Optima plate reader at 450 nm within 15 min of stopping the reaction. A four-parameter logistic curve (4PL) was used as described above. Intra-assay coefficients of variance (CVs) were 4.7% at 76.2 g/L ± 3.6 (mean ± SD) and 3.7%, at 32.6 g/L ± 1.48 (mean ± SD) (n = 40). Inter-assay CVs were 2.7%, at 43.6 g/L ± 1.17 (mean ± SD) and 5.8%, at 70.8 g/L ± 6.4 (mean ± SD) (n = 5) and the limit of detection was 1.7 g/L (3 SD from zero sample). Table 1 . Shows median ± SD of body weight for control and vaccinated groups at each sampling time. There were no significant differences by Mann-Whitney test, at any sampling time between the groups, n = 6 chicks per sampling time. 
ELISA Assay for SAA
Serum samples (50 μL) were first incubated in a heat block at 60
• C for 1 h to dissociate SAA from lipoproteins. Following heat treatment, the diluted samples and standard (100 μL) were incubated in the antibodycoated microtiter wells in duplicate together with HRP conjugate (100 μL) for 1 h. As a result, SAA molecules become sandwiched between the immobilization and detection antibodies. Contents of the wells were then discarded and wells washed 5 times each using 1× wash buffer. After ensuring all residual droplets in the wells were removed by striking plates onto absorbent paper, 100 μL of TMB Reagent was added and incubated for 20 min. Color development was stopped by the addition of 100 μL Stop Solution, changing the color from blue to yellow and the optical density was measured at 450 nm. A 4PL was used as described above. Intraassay CVs were 5.7% at 57.5 μg/L 4.8 (mean ± SD) and 3.07% at 25.9 μg/L ± 1.8 (mean ± SD) (n = 40), inter assay CVs were 7.6% at 10.5 μg/L ± 0.6 (mean ± SD) and 5.3% at 103.7 μg/L ± 6.2 (mean ± SD) (n = 5) and the limit of detection was 0.21 μg/L (3 SD from zero sample)
Data Handling and Statistical Analysis
The antibody response to the vaccine, H/L ratios, and acute phase proteins (SAA, AGP) of the vaccinated and control groups, were compared at each sampling time point using a Mann-Whitney Test for non-parametric distribution (Minitab 17.1.0). In all analyses, P < 0.05 was used to represent statistical significance.
RESULTS
Chick Weights
The chicks in each group were within the same range, 69.85 g (56.5 to 84.2) median (range) for the control group and for the vaccinated group 76.4 g (60.8 to 81.2) median (range) at 7 d old. There were no significant differences in body weight between the groups in response to the vaccination (Table 1 ). 
Antibody Titer Raised Against the Vaccine
The antibody titer was significantly elevated by 3.1-fold (P < 0.01) after 21 d to be 488AU (346 to 781) median (range) in the vaccinated group compared to the control group 154 AU (130 to 186) median (range) (Figure 1 ).
The Heterophil/Lymphocyte Ratio
The H/L ratio increased significantly (P < 0.01) to reach a peak of 0. Comparison of AGP concentrations in vaccinated (V) (n = 6 per time point) and control groups (C) (n = 6 per time point) over the time course of this study. Significant differences (horizontal bars) were detected at d 2 and d 6 post treatment (P < 0.05). Data of 8 sampling time points are presented in median with 25 to 75 percentile range as the box and the whisker as 10 to 90 percentiles. P < 0.05 (Figure 3) . At d-3 post treatment the AGP levels were not statistically different from the control animals. At d -6 post treatment, another significant increase (P < 0.05) in the levels of AGP in the vaccinated group over controls was observed with a 1.9-fold increase from 0.54 g/L (0.37 to 0.68) median (range) in the control group to 0.99 g/L (0.53 to 1.29) median (range) in the vaccinated group.
SAA levels were significantly higher in the vaccinated group on d 1 post treatment (P < 0.05) with a 2.5-fold increase from 39.5 μg/L (20.6 to 63.7) median (range), in the control group to 103.5 μg/L (61 to 180.9) median (range), in the vaccinated group. Thereafter, there was no significant difference except on d 6 PV, when the SAA concentration was significantly higher in the vaccination group with a 2.8-fold (P < 0.01) increase from 42.5 μg/L (22.7 to 63.3) median (range) in the control 
DISCUSSION
This investigation showed that an intra-ocular vaccination of SPF layer chicks with a dual vaccine against Newcastle disease virus and infectious bronchitis causes an immediate but mild APP response, with small increases in AGP and SAA on d 2 and d 1 PV, respectively. We also demonstrated that the vaccinated birds underwent a mild vaccination stress response with H/L ratios remaining higher in the vaccinated birds for up to 3 d PV. The efficacy of the vaccine to produce antibody to the immunogens contained, was confirmed by demonstration of the presence of specific antibody on d 21 PV.
The SAA concentration in many species is related to the severity or virulence of the pathogen, and it can be used as marker for detection of inflammation (Eckersall, 1995; Ceron et al., 2005) , serving as an indicator of the immediate innate immune response to stimulations such as vaccination. SAA usually increases within several hours (5 to 6 h in humans) of an inflammatory event and decreases after 48 h and typically increases 10-to 100-fold during a response (Kushner and Rzewnicki, 1994; Gruys et al., 2005 ). In the current study, the intraocular administration of N/B vaccine stimulated only a mild increase in the SAA concentration, though the serum SAA increased significantly at 24 h post treatment, with a 2.4-fold elevation, as is seen with vaccination in other species. For instance, SAA levels increased sharply from 5 h to hit the peak at 24 h to be 3.6-fold higher than the previous level before inoculation following intratracheal inoculation of beef calves with inactivated Pasteurella multocida (Dowling et al., 2004) . In lambs, subcutaneous vaccination with Heptavac P (combined Clostridia and Pasteurella vaccine) also caused a significant increase (P < 0.01) in both SAA and haptoglobin (Hp). The level of SAA peaked at 24 h, reaching a 400-fold increase, and did not return to normal concentration until 4 d later (Eckersall et al., 2008) .
In the current study, we observed a second elevation of SAA in the vaccinated group compared to the control group on d 6 post treatment, which also coincided with a second peak in AGP concentration. A limitation of our study was that we were not able to repeat sample the same individual chicks, so it is not possible to determine if this second peak in APP was present because some individuals responded more slowly to the vaccination or if some other factor was coming into play, e.g., social stress. The most likely explanation is that the second APP peak was due to individual differences in the APP response (Verschuur et al., 2004; Elsasser et al., 2005) .
In the current study, AGP in the vaccinated group was significantly higher by a 2-fold increase at 2 d post treatment. This result is similar to that reported by Sylte and Suarez (2012) , who reported an AGP peak serum concentration of 2.6 -fold at 48 h postexperimental infection with influenza virus in 4 wk old White Leghorn chickens. However, we did not see a prolonged increase in AGP unlike the 96 h increase reported by these authors. Notably the intraocular inoculation with a vaccine strain of Gumboro disease virus lead to a 2.4-fold increase in plasma AGP at d 4 post treatment in 3 wk old white leghorn SPF chickens (Inoue et al., 1997) whereas intraocular inoculation with a highly virulent strain of Gumboro disease virus lead to an increase of plasma AGP at d 2 which peaked at d 6 post treatment (6.2-fold increase).
Measuring the H/L ratio has been established as means of evaluating stress in chickens (McFarlane and Curtis, 1989; Maxwell et al., 1992; Puvadolpirod and Thaxton, 2000; Post et al., 2003) . In the current study, we observed an increase in heterophils and a decrease in lymphocytes in the vaccinated group, whereas the control animals did not show any significant change in their H/L ratios. The changes we observed in the H/L ratios was therefore likely to be related to the vaccine action and its effects on the innate immune response. These inflammatory mediators also initiate and modulate the APR, which by diffusing into the extracellular fluid and circulating in the blood, leads to the activation of the hypothalamic-pituitary-adrenal axis, decrease production of growth hormone and physiological changes as fever, lack of apatite and catabolism of muscle cells (Gruys et al., 2005) . As a result, inflammation may have a combined effect on the H/L ratio by increasing heterophil concentrations due to increased granulocytopoiesis and decreasing lymphocyte concentration due to cytokine-mediated increases in corticosterone concentration (Clark, 2015) . Change of the H/L ratio has been reported in birds to be 0.19 to 64.67 in different diseases (Clark, 2015) , so for our vaccinated birds, a change in H/L from 0.11 to 0.54 is suggestive of a mild stress response.
Taken together, the vaccination procedure used in this study caused only a mild APR with only small increases in AGP and SAA, and a mild change in H/L ratios. This contrasts with results of PV acute phase reactions in other species and with other types of vaccine. In previous reports, the use of an adjuvant may have aided and enhanced the APR, e.g., in rabbit (Destexhe et al., 2013) and sheep (Eckersall et al., 2008) . Thus, the absence of an adjuvant in the current N/B vaccine and administration by the intra-ocular route may have led to a moderate stimulation of the acute phase and stress responses.
In conclusion, vaccination of chicks with N/B vaccine by the intra-ocular route produced a mild acute phase response and vaccination stress response in 7-day-old SPF layer chicks. Of the 2 methods, the H/L ratio was more sensitive and consistent in terms of measuring the mild vaccination stress response under the conditions employed in this experiment. While the SAA and AGP levels increased within 1 and 2 d PV respectively, a limitation of the design of this experiment was that individual differences in the APR response could not be taken into account. For future work, it will be of interest to monitor the APR in the same individuals using different vaccines and routes of administration and to assess whether the post vaccine APPs response is correlated to both the H/L ratio and the subsequent antibody Titer. In addition, characterizing PV responses in chickens could be a way of assessing the dynamic APR and evaluating its potential as a biomarker for disease resistance.
